ATE537248T1 - Modulation der angiogenese durch bartonella henselae - Google Patents

Modulation der angiogenese durch bartonella henselae

Info

Publication number
ATE537248T1
ATE537248T1 AT04791033T AT04791033T ATE537248T1 AT E537248 T1 ATE537248 T1 AT E537248T1 AT 04791033 T AT04791033 T AT 04791033T AT 04791033 T AT04791033 T AT 04791033T AT E537248 T1 ATE537248 T1 AT E537248T1
Authority
AT
Austria
Prior art keywords
angiogenesis
modulation
nucleic acid
acid molecule
bartonella henselae
Prior art date
Application number
AT04791033T
Other languages
English (en)
Inventor
Volkhard Kempf
Tanja Riess
Ingo Autenrieth
Kari Alitalo
Siv Anderson
Original Assignee
Univ Eberhard Karls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Eberhard Karls filed Critical Univ Eberhard Karls
Application granted granted Critical
Publication of ATE537248T1 publication Critical patent/ATE537248T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
AT04791033T 2003-11-05 2004-10-29 Modulation der angiogenese durch bartonella henselae ATE537248T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10351627A DE10351627B4 (de) 2003-11-05 2003-11-05 Modulation der Angiogenese durch Bartonella henselae
PCT/EP2004/012273 WO2005049786A2 (en) 2003-11-05 2004-10-29 Modulation of angiogenesis by bartonella henselae

Publications (1)

Publication Number Publication Date
ATE537248T1 true ATE537248T1 (de) 2011-12-15

Family

ID=34584883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791033T ATE537248T1 (de) 2003-11-05 2004-10-29 Modulation der angiogenese durch bartonella henselae

Country Status (5)

Country Link
US (1) US7638489B2 (de)
EP (1) EP1680499B8 (de)
AT (1) ATE537248T1 (de)
DE (1) DE10351627B4 (de)
WO (1) WO2005049786A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10351627B4 (de) * 2003-11-05 2012-11-15 Eberhard-Karls-Universität Tübingen Universitätsklinikum Modulation der Angiogenese durch Bartonella henselae
FR2943915B1 (fr) * 2009-04-03 2011-04-08 Agronomique Inst Nat Rech Utilisation vaccinale d'un fragment d'adhesine de bartonella
JP7229519B2 (ja) * 2019-02-20 2023-02-28 学校法人藤田学園 血管新生促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406887B1 (en) * 1992-01-17 2002-06-18 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection
EP1454987A1 (de) * 2003-03-05 2004-09-08 Universität Basel Vom Typ IV System VirB/VirD4 in Zellen translozierte Polypeptide und ihre Verwendungen
DE10351627B4 (de) * 2003-11-05 2012-11-15 Eberhard-Karls-Universität Tübingen Universitätsklinikum Modulation der Angiogenese durch Bartonella henselae

Also Published As

Publication number Publication date
DE10351627B4 (de) 2012-11-15
WO2005049786A3 (en) 2005-07-21
WO2005049786A2 (en) 2005-06-02
EP1680499A2 (de) 2006-07-19
EP1680499B1 (de) 2011-12-14
DE10351627A1 (de) 2005-06-16
EP1680499B8 (de) 2012-03-21
US7638489B2 (en) 2009-12-29
US20060286122A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
WO2000003685A3 (en) Nitrilase homologs
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
DE502004011932D1 (de) Verfahren zur herstellung von 3-methylamino-1-(thien-2-yl)-propan-1-ol
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
ATE547519T1 (de) Gerinnungsfaktor-vii-polypeptide
ATE537248T1 (de) Modulation der angiogenese durch bartonella henselae
WO2004096856A3 (en) Secreted protein family
DK1587828T3 (da) Defensivproteiner
WO2006000213A3 (de) Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen
AR025482A1 (es) Secuencia de adn que codifica una proteina capaz de ligarse a traf; vector que comprende dicha secuencia; celulas huespedes transformadas con dicho vector;proteinas iren codificadas por dicha secuencia; metodo para producir dicha proteina; anticuerpos especificos para dichas proteinas; metodo para m
WO2005049793A3 (en) Methods and compositions for combinatorial approaches to cancer gene therapy
MXPA05009954A (es) Familia de proteinas secretadas.
DE60128802D1 (de) Verfahren zum nachweis von genen von sekretierten proteinen
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
ATE526400T1 (de) Metalloproteaseproteine
ATE454472T1 (de) C1ckb-mutation als diagnostisches und therapeutisches ziel
WO2001057186A3 (en) Methods and compositions for diagnosis and treatment of cancer based on esf
MXPA05012414A (es) Proteina secretada similar a tnf.
WO2004026905A3 (en) Transporter/channel proteins
EP1536010A4 (de) Preventive/heilmittel gegen krebs
WO2007049062A3 (en) Vwfa-domain containing proteins
WO2003054178A3 (en) Metalloprotease proteins
WO2004000882A3 (en) Proteins
WO2003091393A3 (en) Nucleic “acid molecules encoding human proteins, and uses thereof”
WO2008017831A8 (en) Secreted vit domain containing proteins